miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer

References

• Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM et al. Stromal biology and therapy in pancreatic cancer. Gut 2011; 60:861-8; PMID:20966025; http://dx.doi.org/10.1136/gut.2010.226092
   PubMed Web of Science ®Google Scholar
• Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012; 18:4266-76; PMID:22896693; http://dx.doi.org/10.1158/1078-0432.CCR-11-3114
   PubMed Web of Science ®Google Scholar
• Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67:9518-27; PMID:17909062; http://dx.doi.org/10.1158/0008-5472.CAN-07-0175
   PubMed Web of Science ®Google Scholar
• Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, Lohr JM, Friess H. Pancreatic cancer microenvironment. Int J Cancer Journal international du cancer 2007; 121:699-705; PMID:17534898; http://dx.doi.org/10.1002/ijc.22871
   PubMed Web of Science ®Google Scholar
• Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331:1612-6; PMID:21436454; http://dx.doi.org/10.1126/science.1198443
   PubMed Web of Science ®Google Scholar
• Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21:822-35; PMID:22698406; http://dx.doi.org/10.1016/j.ccr.2012.04.025
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41:49-61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18:349-55; PMID:18467122; http://dx.doi.org/10.1016/j.semcancer.2008.03.004
   PubMed Web of Science ®Google Scholar
• Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S, Takao S. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011; 167:e211-9; PMID:19765725; http://dx.doi.org/10.1016/j.jss.2009.05.026
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhao L, Zhu LY, He M, Zheng L, Wu Y. MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2alpha. PloS One 2013; 8:e77890; PMID:24194900; http://dx.doi.org/10.1371/journal.pone.0077890
   PubMed Web of Science ®Google Scholar
• Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, Gentner B, Naldini L. A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 2013; 122:243-52; PMID:23487026; http://dx.doi.org/10.1182/blood-2012-08-449306
   PubMed Web of Science ®Google Scholar
• Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L et al. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 2012; 1:141-54; PMID:22832163; http://dx.doi.org/10.1016/j.celrep.2011.12.005
   PubMed Web of Science ®Google Scholar
• Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437-50; PMID:14706336; http://dx.doi.org/10.1016/S1535-6108(03)00309-X
   PubMed Web of Science ®Google Scholar
• Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005; 7:469-83; PMID:15894267; http://dx.doi.org/10.1016/j.ccr.2005.04.023
   PubMed Web of Science ®Google Scholar
• Karnevi E, Andersson R, Rosendahl AH. Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion. Immunol Cell Biol 2014; 92:543-52; PMID:24662521; http://dx.doi.org/10.1038/icb.2014.22
   PubMed Web of Science ®Google Scholar
• Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schworer AM, Wagner U, Muller-Brusselbach S et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer Journal international du cancer 2014; 134:32-42; PMID:23784932; http://dx.doi.org/10.1002/ijc.28335
   PubMed Web of Science ®Google Scholar
• Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Borresen-Dale AL, Santarpia L. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res 2015; 21:1207-14; PMID:25547678; http://dx.doi.org/10.1158/1078-0432.CCR-14-2011
   PubMed Web of Science ®Google Scholar
• Yu H, Lu Y, Li Z, Wang Q. microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer. Curr Drug Targets 2014; 15:817-28; PMID:24975488; http://dx.doi.org/10.2174/1389450115666140627104151
   PubMed Web of Science ®Google Scholar
• Li ZW, Yang YM, Du LT, Dong Z, Wang LL, Zhang X, Zhou XJ, Zheng GX, Qu AL, Wang CX. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Med Oncol 2014; 31:256; PMID:25270282; http://dx.doi.org/10.1007/s12032-014-0256-5
   PubMed Web of Science ®Google Scholar
• Liu Q, Zou R, Zhou R, Gong C, Wang Z, Cai T, Tan C, Fang J. miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro. J Cell Biochem 2015; 116:1213-21; PMID:25535908; http://dx.doi.org/10.1002/jcb.25073
   PubMed Web of Science ®Google Scholar
• Yang CH, Pfeffer SR, Sims M, Yue J, Wang Y, Linga VG, Paulus E, Davidoff AM, Pfeffer LM. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis. J Biol Chem 2015; 290:6037-46; PMID:25589783; http://dx.doi.org/10.1074/jbc.M114.632125
   PubMed Web of Science ®Google Scholar
• Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11:1487-95; PMID:19935649; http://dx.doi.org/10.1038/ncb1998
   PubMed Web of Science ®Google Scholar
• Permuth-Wey J, Chen YA, Fisher K, McCarthy S, Qu X, Lloyd MC, Kasprzak A, Fournier M, Williams VL, Ghia KM et al. A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. PloS One 2015; 10:e0116869; PMID:25607660; http://dx.doi.org/10.1371/journal.pone.0116869
   PubMedGoogle Scholar
• Li L, Zhang J, Diao W, Wang D, Wei Y, Zhang CY, Zen K. MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells. J Immunol 2014; 192:1034-43; PMID:24391219; http://dx.doi.org/10.4049/jimmunol.1301309
   PubMed Web of Science ®Google Scholar
• Doberstein K, Bretz NP, Schirmer U, Fiegl H, Blaheta R, Breunig C, Muller-Holzner E, Reimer D, Zeimet AG, Altevogt P. miR-21-3p is a positive regulator of L1CAM in several human carcinomas. Cancer Lett 2014; 354:455-66; PMID:25149066; http://dx.doi.org/10.1016/j.canlet.2014.08.020
   PubMed Web of Science ®Google Scholar
• Bernardini G, Sciume G, Bosisio D, Morrone S, Sozzani S, Santoni A. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 2008; 111:3626-34; PMID:18227348; http://dx.doi.org/10.1182/blood-2007-08-106203
   PubMed Web of Science ®Google Scholar
• Kuhnemuth B, Muhlberg L, Schipper M, Griesmann H, Neesse A, Milosevic N, Wissniowski T, Buchholz M, Gress TM, Michl P. CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-kappaB signaling. Oncogene 2015; 34:177-87; PMID:24336331; http://dx.doi.org/10.1038/onc.2013.530
   PubMed Web of Science ®Google Scholar
• Krug S, Huth J, Goke F, Buchholz M, Gress TM, Goke R, Lankat-Buttgereit B. Knock-down of Pdcd4 stimulates angiogenesis via up-regulation of angiopoietin-2. Biochimica et biophysica acta 2012; 1823:789-99; PMID:22289349; http://dx.doi.org/10.1016/j.bbamcr.2012.01.006
   PubMed Web of Science ®Google Scholar
• Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, Lowe SW. Non-cell-autonomous tumor suppression by p53. Cell 2013; 153(2):449-60; PMID:23562644; http://dx.doi.org/10.1016/j.cell.2013.03.020
   PubMed Web of Science ®Google Scholar
• Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-9; PMID:17332291; http://dx.doi.org/10.1158/1078-0432.CCR-06-2073
   PubMed Web of Science ®Google Scholar
• Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, Palmqvist R. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PloS One 2012; 7:e47045; PMID:23077543; http://dx.doi.org/10.1371/journal.pone.0047045
   PubMed Web of Science ®Google Scholar
• Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren H, Vogel I, Kruger U, Becker T, Ebsen M, Rocken C et al. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer Journal international du cancer 2014; 135:843-61; PMID:24458546; http://dx.doi.org/10.1002/ijc.28736
   PubMed Web of Science ®Google Scholar
• Sebens S, Bauer I, Geismann C, Grage-Griebenow E, Ehlers S, Kruse ML, Arlt A, Schafer H. Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. J Biol Chem 2011; 286:40911-21; PMID:21990354; http://dx.doi.org/10.1074/jbc.M111.274902
   PubMed Web of Science ®Google Scholar
• Wang W, Li X, Zheng D, Zhang D, Huang S, Zhang X, Ai F, Wang X, Ma J, Xiong W et al. Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model. Inflamm Res [et al] 2013; 62:669-80; PMID:23625042; http://dx.doi.org/10.1007/s00011-013-0619-y
   PubMed Web of Science ®Google Scholar
• Challagundla KB, Fanini F, Vannini I, Wise P, Murtadha M, Malinconico L, Cimmino A, Fabbri M. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn 2014; 14:565-74; PMID:24844135; http://dx.doi.org/10.1586/14737159.2014.922879
   PubMed Web of Science ®Google Scholar
• Song YQ, Ma XH, Ma GL, Lin B, Liu C, Deng QJ, Lv WP. MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8. Diagn Pathol 2014; 9:164; PMID:25163571; http://dx.doi.org/10.1186/s13000-014-0164-1
   PubMed Web of Science ®Google Scholar
• Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C et al. CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. Oncogene 2014; PMID:25241894; http://dx.doi.org/10.1038/onc.2014.294
   PubMedGoogle Scholar
• Dikshit B, Irshad K, Madan E, Aggarwal N, Sarkar C, Chandra PS, Gupta DK, Chattopadhyay P, Sinha S, Chosdol K. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells. Oncogene 2013; 32:3798-808; PMID:22986533; http://dx.doi.org/10.1038/onc.2012.393
   PubMed Web of Science ®Google Scholar
• Das A, Ganesh K, Khanna S, Sen CK, Roy S. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol 2014; 192:1120-9; PMID:24391209; http://dx.doi.org/10.4049/jimmunol.1300613
   PubMed Web of Science ®Google Scholar
• Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci U S A 2002; 99:6181-6; PMID:11972057; http://dx.doi.org/10.1073/pnas.092141999
   PubMed Web of Science ®Google Scholar
• Sheedy FJ. Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response. Front Immunol 2015; 6:19; PMID:25688245; http://dx.doi.org/10.3389/fimmu.2015.00019
   PubMed Web of Science ®Google Scholar
• Ripka S, Neesse A, Riedel J, Bug E, Aigner A, Poulsom R, Fulda S, Neoptolemos J, Greenhalf W, Barth P et al. CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut 2010; 59:1101-10; PMID:20442202; http://dx.doi.org/10.1136/gut.2009.189720
   PubMed Web of Science ®Google Scholar
• Baumgart S, Glesel E, Singh G, Chen NM, Reutlinger K, Zhang J, Billadeau DD, Fernandez-Zapico ME, Gress TM, Singh SK et al. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. Gastroenterology 2012; 142:388-98 e1-7; PMID:22079596; http://dx.doi.org/10.1053/j.gastro.2011.11.001
   PubMed Web of Science ®Google Scholar